RI-mediated activation
Introduction
Recently, cytokines homologous to interleukin (IL)-17 have been identified by database searching. There have been 5 new family members identified, namely IL-17B, IL-17C, IL-17D, IL-17E/IL-25, and IL-17F, which possess 20% to 30% homology to IL-17. 1, 2 Among IL-17 family cytokines, it has been shown that the in vivo and in vitro biologic activities of IL-25 are markedly different from those described for IL-17 and other IL-17 family cytokines. [2] [3] [4] [5] [6] [7] The expression of IL-25 results in the expansion of eosinophils through the production of IL-5 from an unidentified non-T-cell population, [2] [3] [4] whereas other IL-17 family cytokines induce the expansion of neutrophils. [5] [6] [7] In addition, IL-25 induces elevated gene expression of IL-4 and IL-13 in multiple tissues and the resultant T helper 2 (T H 2)-type immune responses (increased serum immunoglobulin E [IgE] levels and pathologic changes in the lungs and digestive tract with eosinophilic infiltrates, increased mucus production, and epithelial cell hyperplasia, 2-4 ), indicating that IL-25 is capable of amplifying allergic inflammation.
Although it has been shown that IL-25 mRNA is exclusively expressed in polarized T H 2 cells, 4 quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) analysis shows that IL-25 mRNA is detected in multiple tissues, including colon, uterus, stomach, small intestine, kidney, and lung, [2] [3] [4] suggesting that, in addition to T H 2 cells, other cell types may produce IL-25. We show here that primary bone marrow-derived mast cells (BMMCs) produce IL-25 upon IgE crosslinking, suggesting that, in addition to T H 2 cells, mast cells are potent IL-25 producers and mast cell-derived IL-25 may be involved in the augmentation of T H 2-type immune response.
Study design

Cell culture
BMMCs were prepared and cultured as described previously. 8 More than 98% of cells obtained after 4 weeks of culture were positive for c-kit expression. CFTL-15 cells 9 were cultured in RPMI 1640 medium containing IL-3. For stimulation of BMMCs via Fc⑀ receptors, BMMCs were first incubated with mouse anti-dinitrophenol (DNP) IgE (1 g/mL, YAMASA, Tokyo, Japan) at 37°C for 2 hours, washed twice with RPMI 1640 medium, and then incubated with DNP-HSA (human serum albumin; 50 ng/mL, Sigma, St Louis, MO) at 37°C for 1 hour. In some experiments, BMMCs were stimulated with IL-3 (10 ng/mL, R&D Systems, Minneapolis, MN), stem cell factor (SCF; 10 ng/mL, a gift from Kirin Brewery, Takasaki, Gunma, Japan), lipopolysaccharide (LPS, 1 g/mL; Sigma), A23187 (500 ng/mL, Sigma), and phorbol myristate acetate (PMA; 100 ng/mL, Sigma) at 37°C for 1 hour. T H 0 cells and T H 2 cells were prepared from DO11.10 T-cell receptor transgenic mice and stimulated as described previously. 10 Splenic B cells and M12.4.5 cells were stimulated with LPS as described elsewhere. 11
RT-PCR assay
Total cellular RNA was prepared and RT-PCR analysis was performed as described previously. 11 The following primer pairs were used for PCR: IL-25 (ATGTACCAGGCTGTTGCATTCTTG and CTAAGCCATGAC-CCGGGGCC), IL-17 (AGGCCCTCAGACTACCTCAACC and GCCTCT-GAATCCACATTCCTTG), IL-17B (CTGACTTGGTGGGATGGACTG and ATTCACGCAACCCAAACATAGG), and tumor necrosis factor ␣ (TNF-␣) (ATGAGCACAGAAAGCATGATCC and GAAGACTCCTC-CCAGGTATATG). Primer pairs for IL-17C, IL-17D, and IL-17F were described elsewhere. 2 RT-PCR for ␤-actin was performed as a control. All PCR amplifications were performed at least 3 times with multiple sets of experimental RNAs.
Taqman PCR analysis
Expression of IL-25 mRNA was determined by real-time Taqman PCR using standard protocol on ABI PRISM 7000 instrument (Applied Biosystems, Foster City, CA). The following PCR primers and a fluorogenic probe were used: sense primer CACACTGCGTCAGCCTACAGA, antisense primer TGTGGTAAAGTGGGACGGAGTT, and probe FAM CTCCCA-CATGGACCCGCTGGG TAMARA. Taqman PCR for TNF-␣ was performed as described previously. 3 The levels of IL-25 or TNF-␣ mRNA were normalized to the levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (Applied Biosystems).
Immunoblotting
After BMMCs were stimulated with A23187 ϩ PMA at 37°C for 3 hours, culture supernatant was collected by centrifugation, concentrated with Microcon (Millipore, Billerica, MA), and separated on 12% sodium dodecyl sulfate (SDS) gel. Rabbit antisera to murine IL-25 were produced using synthetic peptide (CPSKEQEPPEEW) as an antigen according to the standard protocol. 12 The antigenic peptide did not exhibit any significant similarity to other IL-17 family members. Immunoblotting was performed as described previously. 13 
Results and discussion
To determine whether mast cells produce IL-25 upon activation, we first examined the expression of IL-25 mRNA in BMMCs by RT-PCR analysis. When BMMCs were stimulated with IgE cross-linking by anti-DNP IgE ϩ DNP-HSA, BMMCs produced IL-25 mRNA at levels comparable with those of activated T H 2 cells ( Figure 1A) . We also obtained similar results using sorted c-kit-positive BMMCs (data not shown). CFTL-15 cells, a mast cell line, also expressed IL-25 mRNA upon activation with A23187 ϩ PMA ( Figure 1A ). In addition, we confirmed the expression of IL-25 mRNA by sequencing. By contrast, neither splenic B cells nor a B-cell line (M12 cells) expressed IL-25 mRNA upon activation with LPS ( Figure 1A ). Among various conditions we tested, the best stimulation for IL-25 mRNA expression in BMMCs was IgE cross-linking (anti-DNP IgE ϩ DNP-HSA) or A23187 ϩ PMA ( Figure 1B) . A23187 alone or PMA alone induced IL-25 mRNA expression at lower levels ( Figure 1B) . LPS also weakly induced IL-25 mRNA expression ( Figure 1B) . On the other hand, neither IL-3 nor SCF induced IL-25 mRNA expression in BMMCs ( Figure 1B) . Interestingly, cyclosporin A inhibited IL-25 mRNA expression induced by IgE cross-linking ( Figure 1B) . Real-time PCR analysis revealed that cyclosporin A significantly decreased the IL-25 mRNA expression by 88% (n ϭ 4, P Ͻ .01) ( Figure 1C ). These results suggest that a calcineurin-dependent pathway is essential for IL-25 mRNA expression in IgE-stimulated mast cells.
We next examined the kinetics of IL-25 mRNA expression in mast cells. As shown in Figure 1D , IL-25 mRNA expression reached a peak within 1 hour after stimulation and decreased to the baseline levels at 3 hours. The peak of IL-25 production was faster than that of TNF-␣ production ( Figure 1D ). In addition, analogous kinetics of IL-25 as well as TNF-␣ production was observed by real-time PCR analysis ( Figure  1E ). Moreover, we found that a 513-base pair (bp) fragment of the 5Ј region of IL-25 gene exhibited the responsiveness to A23187 ϩ PMA stimulation in CFTL-15 cells (data not shown), suggesting that IL-25 mRNA is induced by the direct activation of the IL-25 promoter. /mL) for one hour. BMMCs were incubated with anti-DNP IgE for 2 hours and then surface IgE was cross-linked with DNP-HSA for 1 hour. CFTL-15 cells were stimulated with A23187 (500 ng/mL) ϩ PMA (100 ng/mL) for one hour. Total cellular RNA was prepared from these cells, and RT-PCR for IL-25 and ␤-actin (as a control) mRNA was performed. Preliminary experiments revealed that the peak of IL-25 mRNA expression in anti-CD3-stimulated TH2 cells was one hour after stimulation. Shown are representative data from 5 independent experiments. (B) Cyclosporin A inhibits IL-25 mRNA induction in mast cells. BMMCs were stimulated with the following stimuli for one hour: IL-3 (10 ng/mL), SCF (10 ng/mL), LPS (1 g/mL), anti-DNP IgE, anti-DNP IgE ϩ DNP-HSA, A23187 (500 ng/mL), PMA (100 ng/mL), and A23187 ϩ PMA. Where indicated, cyclosporin A (CyA) was added at 1 g/mL. RT-PCR analysis for IL-25 and ␤-actin mRNA was performed as described in "Study design." Shown are representative data from 4 independent experiments. (C) Real-time PCR analysis for the effect of cyclosporin A. BMMCs were incubated with anti-DNP IgE alone or anti-DNP IgE ϩ DNP-HSA for one hour in the presence or absence of cyclosporin A (1 g/mL). Real-time PCR analysis for IL-25 as well as GADPH (as a control) mRNA was performed, and the levels of IL-25 mRNA were normalized to the levels of GADPH mRNA. only.
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To examine IL-25 production at protein levels, we generated antisera to murine IL-25. The antisera could detect recombinant murine IL-25 but did not react with IL-17 ( Figure 1F ). When BMMCs were stimulated with A23187 ϩ PMA for 3 hours and culture supernatant was subjected to immunoblotting, a specific band was detected at approximately 17 kDa with antisera to murine IL-25 but not with preimmune serum (Figure 1G ). These results suggest that BMMCs release IL-25 protein upon activation.
Finally, to determine whether mast cells selectively produce IL-25, we performed RT-PCR analysis for other IL-17 family cytokines (IL-17, IL-17B, IL-17C, IL-17D, or IL-17F). Interestingly, in addition to IL-25 mRNA, BMMCs expressed IL-17F mRNA upon IgE cross-linking (Figure 2 ). In contrast, BMMCs did not express mRNA for IL-17, IL-17B, IL-17C, or IL-17D (Figure 2 and data not shown). On the other hand, activated T H 2 cells expressed mRNA not only for IL-25 and IL-17F but also for IL-17 (Figure 2) , suggesting that the expression of IL-17 family cytokines is differently regulated between mast cells and T H 2 cells.
In summary, we show that, upon IgE cross-linking, mast cells produce IL-25. Because IL-25 induces IgE production and eosinophilic inflammation in multiple tissues through the expression of IL-4, IL-5, and IL-13, our findings suggest that mast cell-derived IL-25 may play a pivotal role in IgE-dependent atopic diseases.
